Literature DB >> 31993888

Physician-patient alignment in satisfaction with psoriatic arthritis treatment in Latin America.

Enrique Roberto Soriano1, Federico Zazzetti2, Ivanio Alves Pereira3, José Maldonado Cocco4, Valderilio Feijó Azevedo5, Generoso Guerra6, Wilson Bautista-Molano7, Julio César Casasola8, David Vega Morales9, Diana Rocío Gil10, Steve Lobosco11, Fabio Lawson12.   

Abstract

INTRODUCTION: Physician-patient misalignment may exist in real-life clinical practice. We aimed to assess physician and patient treatment satisfaction levels and associated degree of misalignment in psoriatic arthritis (PsA).
METHOD: Data from a cross-sectional survey of patients and their physicians conducted in Latin America were analyzed. Physician-reported and patient-reported satisfaction levels with current PsA treatment, alignment in satisfaction levels, and factors associated with satisfaction misalignment were assessed through bivariable and multivariable regression analyses.
RESULTS: A total of 179 physician-patient pairs were analyzed. Physicians reported satisfaction with current disease control in 87.7% (n = 157) of cases; patients reported satisfaction in 91.1% (n = 163 of cases). A total of 82.1% of physician-patient pairs were aligned. Compared with aligned patients, misaligned patients were older and more likely to have moderate or severe disease, deteriorating or unstable disease, a past hospital procedure, current or past psoriasis symptoms, greater current pain, a current acute episode, poorer health and quality of life, greater impairment, poorer medication compliance, to consider PsA a major daily burden, and to believe that PsA treatments were ineffective. Misaligned patients were less likely to be in remission. Logistic regression analysis revealed that misaligned patients were older, and more likely to consider PsA a major daily burden and PsA treatments as ineffective.
CONCLUSIONS: High levels of treatment satisfaction and alignment were observed among PsA patients and their physicians in Latin America. Patients in this study nevertheless experienced a considerable clinical and quality-of-life burden, especially the misaligned patients. Addressing misalignment may lead to improved PsA disease control.Key points• High treatment satisfaction was observed among PsA patients and their treating physicians in Latin America.• Patients experienced a considerable clinical and quality-of-life burden, especially the misaligned patients.• One-fifth of physician-patient pairs were misaligned regarding satisfaction.• Understanding and addressing misalignment may improve outcomes in this patient population.

Entities:  

Keywords:  Biological therapy; Latin America; Patient engagement; Psoriatic arthritis; Treatment satisfaction

Mesh:

Substances:

Year:  2020        PMID: 31993888     DOI: 10.1007/s10067-019-04870-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  29 in total

1.  Prevalence of psoriatic arthritis in a large cohort of Brazilian patients with psoriasis.

Authors:  Roberto Ranza; Sueli Carneiro; Abrar A Qureshi; Gladys Martins; Jose Joaquim Rodrigues; Ricardo Romiti; Thiago Bitar M Barros; Jamille Carneiro; Ana Luisa Sampaio; Rachel Grynszpan; Juliana Markus; Rogerio Melo Costa Pinto; Claudia Goldenstein-Schainberg
Journal:  J Rheumatol       Date:  2015-03-01       Impact factor: 4.666

Review 2.  New treatment paradigms in psoriatic arthritis: an update on new therapeutics approved by the U.S. Food and Drug Administration.

Authors:  Maria L Acosta Felquer; Enrique R Soriano
Journal:  Curr Opin Rheumatol       Date:  2015-03       Impact factor: 5.006

3.  Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers.

Authors:  Mark J Atkinson; Ritesh Kumar; Joseph C Cappelleri; Steven L Hass
Journal:  Value Health       Date:  2005 Nov-Dec       Impact factor: 5.725

4.  Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria.

Authors:  Hernán Maldonado Ficco; Gustavo Citera; José Antonio Maldonado Cocco
Journal:  Clin Rheumatol       Date:  2013-10-24       Impact factor: 2.980

5.  European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.

Authors:  L Gossec; J S Smolen; S Ramiro; M de Wit; M Cutolo; M Dougados; P Emery; R Landewé; S Oliver; D Aletaha; N Betteridge; J Braun; G Burmester; J D Cañete; N Damjanov; O FitzGerald; E Haglund; P Helliwell; T K Kvien; R Lories; T Luger; M Maccarone; H Marzo-Ortega; D McGonagle; I B McInnes; I Olivieri; K Pavelka; G Schett; J Sieper; F van den Bosch; D J Veale; J Wollenhaupt; A Zink; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2015-12-07       Impact factor: 19.103

Review 6.  The pathogenesis of psoriatic arthritis.

Authors:  Douglas J Veale; Ursula Fearon
Journal:  Lancet       Date:  2018-06-01       Impact factor: 79.321

Review 7.  Clinical management of psoriatic arthritis.

Authors:  Filip Van den Bosch; Laura Coates
Journal:  Lancet       Date:  2018-06-01       Impact factor: 79.321

Review 8.  Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues.

Authors:  Richard Shikiar; Anne M Rentz
Journal:  Value Health       Date:  2004 Mar-Apr       Impact factor: 5.725

9.  Comparison between two generic questionnaires to assess satisfaction with medication in chronic diseases.

Authors:  Stéphanie Delestras; Matthieu Roustit; Pierrick Bedouch; Mélanie Minoves; Valérie Dobremez; Roseline Mazet; Audrey Lehmann; Magalie Baudrant; Benoît Allenet
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

10.  Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease.

Authors:  Mark J Atkinson; Anusha Sinha; Steven L Hass; Shoshana S Colman; Ritesh N Kumar; Meryl Brod; Clayton R Rowland
Journal:  Health Qual Life Outcomes       Date:  2004-02-26       Impact factor: 3.186

View more
  2 in total

Review 1.  Disease activity indices in psoriatic arthritis: current and evolving concepts.

Authors:  Chrysoula G Gialouri; George E Fragoulis
Journal:  Clin Rheumatol       Date:  2021-05-18       Impact factor: 2.980

2.  Gaps in moderate plaque psoriasis management: A survey of Saudi dermatologists.

Authors:  Mohammad Almohideb; Nora Abdulrahman Almohideb
Journal:  J Family Med Prim Care       Date:  2021-12-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.